PROVIDER PROFILE · NPI 1912946005

Michael Rigsby

Internal MedicineNew Haven, CTI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

Beneficiaries

—

Total drug cost

$92K

Distinct drugs

Brand share

69.2%

Top prescribed drugs

Dolutegravir Sodium/Lamivudine14 claims

Bictegrav/Emtricit/Tenofov Ala13 claims

Amlodipine Besylate12 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Michael Rigsby's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 6 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Quest Diagnostics Llc Clinical Laboratory · Wallingford, CT	194	390
Slawomir Mejnartowicz Internal Medicine · New Haven, CT	61	92
John Toksoy Internal Medicine · New Haven, CT	51	89
FORSTER, SUSAN	25	32
American Medical Response Of Connecticut Incorporated Ambulance Service Provider · New Haven, CT	15	24
YALE NEW HAVEN HOSPITAL	11	17

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history